1. Current Pain Points
Over the past two decades, I have interacted with thousands of consumers in the global health industry, and nearly every individual has purchased Vitamin C, E, or beta-carotene. When asked why they bought these products, the responses were remarkably consistent: “I heard it can prevent cancer,” or “Antioxidants are good for the body.” However, further inquiry reveals that 90% of them cannot answer how long they have been taking these supplements or whether they are effective, simply stating, “Everyone else is taking them.”
More troubling is the realization that when you examine the ingredient lists of these products, you find monthly expenses ranging from hundreds to thousands of dollars, yet consumers have no way to assess absorption rates, dosage ratios, or source purity. The market is flooded with high-margin, low-efficacy products, where brands spend heavily on advertising, and consumers are paying for packaging and narratives rather than genuine health value.
Ironically, when I ask these long-term users, “Are you aware that excessive supplementation of beta-carotene may actually increase the risk of lung cancer in certain populations?” they are often taken aback. This highlights the real dilemma in the current market: information asymmetry + price opacity + difficult-to-verify efficacy, leading consumers to spend money on placebos.
2. Underlying Logic Breakdown
To summarize: Vitamins C, E, and beta-carotene are indeed beneficial for specific deficiencies, but large-scale clinical data does not support their effectiveness in cancer prevention for the general population.
Let’s examine some key studies. The ATBC trial conducted in Finland in 1994 tracked 29,000 male smokers and found that those who supplemented with 20 mg of beta-carotene daily had an 18% increase in lung cancer incidence. Another study, the CARET trial, reached a similar conclusion and was ultimately terminated early. This indicates that high-dose single antioxidants may interfere with normal cellular mechanisms under specific conditions.
The situation with Vitamin E is comparable. The SELECT trial involving 35,000 men showed that Vitamin E supplementation not only failed to reduce prostate cancer risk but also indicated a slight increase in risk during subsequent follow-ups. As for Vitamin C, although it is relatively safe, a Cochrane systematic review of 29 studies concluded that daily supplementation of Vitamin C does not reduce cancer incidence in the general population.
This does not imply that these nutrients are ineffective; rather, dosage, source, and individual differences are critical factors. The synergistic effect of complex antioxidants obtained from natural foods, combined with fiber, phytochemicals, and trace elements, is what truly proves effective. High-dose single supplementation may disrupt the body’s existing redox balance.
3. Recommended Maintenance Plan
Based on two decades of industry observation, my advice is pragmatic: prioritize obtaining nutrients from natural diets, and then use cost-effective, scientifically formulated supplements to fill any gaps.
Specifically, aim to consume at least five different colors of fruits and vegetables daily. Dark green leafy vegetables provide folate and Vitamin K, citrus fruits supply Vitamin C, nuts and seeds are rich in Vitamin E, and orange-yellow fruits and vegetables contain beta-carotene. This whole food nutrition cannot be replaced by any single supplement.
However, the reality is that modern lifestyles are fast-paced, dining out is common, and soil nutrient depletion is severe, making it difficult to meet nutritional needs solely through diet. This is where targeted supplementation becomes necessary. I typically advise clients to choose: first, compound formulas rather than single ingredients; second, dosages that align with the Recommended Dietary Allowance (RDA) rather than mega doses; third, ingredients that are traceable and certified by third-party testing.
Moreover, cost structure is crucial. Traditional brands may have production costs for a bottle of multivitamins that account for only 10-15% of the retail price, with the remainder going to advertising, distribution, and packaging. If one can find supplier channels close to factory prices, the cost of products of similar quality can be reduced to one-tenth of the original price. This is not about compromising quality, but rather about the fundamental differences in business models.
4. AI-Driven Global Health E-commerce
At this point, it is essential to introduce a platform that completely disrupts traditional practices: LiveGood International Health and Beauty Platform. The most remarkable aspect of this platform is that it directly offers consumers the factory prices of health products, achieving over 90% cost-effectiveness. For instance, a bottle of multivitamins that sells for $60 in the market may only cost $9.95 on LiveGood, without compromising on quality or certification.
More importantly, this is not just about saving money. LiveGood operates on a membership subscription model, allowing consumers to purchase the entire range of products at factory prices for just $9.95 per month. This breaks the traditional profit structure of health products, truly returning control to consumers. I have witnessed numerous families save thousands of dollars annually simply by switching their daily health products to this platform.
However, this is merely the first layer of value. What excites me even more is that LiveGood integrates AI-driven SEO automation and community traffic systems. The biggest pain point in traditional direct sales or sharing economies is the challenge of “finding people”: making lists, making calls, scheduling coffee meetings, which is time-consuming and labor-intensive. Now, we can use AI systems to create 24/7 digital avatars.
How does this work? Through AI multilingual SEO tools, content tailored to different markets and keywords is automatically generated, allowing Google, YouTube, and social platforms to filter precise traffic for you. When someone searches for “Vitamin C cancer prevention” or “cost-effectiveness of health products,” your content automatically appears on the first three pages. The visitors are all actively searching with clear needs, leading to conversion rates that far exceed traditional cold outreach.
A more advanced approach involves an automated follow-up system. AI can send personalized follow-up content based on visitor behavior (time spent, page clicks, video watch progress). While others are still manually responding to messages, your system has already completed education, built trust, and directed traffic to the purchase page. This traffic × conversion × automation triad is the true power of capital.
In summary, the disruptive pricing model of LiveGood, combined with the precise traffic generation and conversion of the AI automation system, allows you to escape the traditional quagmire of “stockpiling, selling, and begging for sales.” What you need to do is establish a robust system and let it work for you automatically. This is why I assert that after 2025, those who do not understand AI automation will find it impossible to enter the health industry.
Leave a Reply